Both compounds independently cause nausea, vomiting, diarrhea, and constipation
The approval makes ENNUMO the eighth pegfilgrastim biosimilar approved in the US, and with it, Accord BioPharma becomes the only company in the United States currently marketing two distinct pegfilgrastim biosimilar products
Understanding why these medications might not be working for you is the first step toward finding a solution that does
J Hypertens 29(3):520528 Pgorier JP, Garcia-Garcia MV, Prip-Buus C, Due PH, Kohl C, Girard J (1989) Induction of ketogenesis and fatty acid oxidation by glucagon and cyclic AMP in cultured hepatocytes from rabbit fetuses
Both require medical oversight, healthy lifestyle habits, and a valid prescription